导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -3.73% | 3191/4981 |
| 近一周 | -1.37% | 3243/5421 |
| 近一月 | -5.82% | 2657/5424 |
| 近一季 | 0.71% | 985/5380 |
| 近半年 | -2.95% | 2665/5140 |
| 近一年 | -10.13% | 3605/4741 |
| 近两年 | 41.67% | 2675/4207 |
| 近三年 | 16.05% | 2419/3662 |
| 成立以来 | 260.36% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.41% 3900/5130 |
4.12% 3144/5464 |
- - |
- - |
| 2025 | 22.04% 2967/5130 |
8.87% 800/4624 |
10.45% 398/4802 |
5.96% 4360/4970 |
-4.22% 3336/5130 |
| 2024 | 10.77% 966/4618 |
4.85% 516/4340 |
-5.26% 3146/4442 |
11.70% 1715/4550 |
-0.17% 1569/4618 |
| 2023 | -21.61% 2815/4216 |
2.96% 1491/3759 |
-12.02% 3541/3909 |
-5.02% 1323/4055 |
-8.88% 3557/4209 |
| 2022 | -16.32% 715/3578 |
-19.81% 1871/2804 |
16.01% 259/3205 |
-14.96% 2369/3430 |
5.77% 530/3570 |
| 2021 | -6.51% 1287/2717 |
4.27% 90/1745 |
6.18% 1290/2232 |
-14.88% 2084/2560 |
-0.80% 1674/2708 |
| 2020 | 59.86% 443/1596 |
2.68% 252/1036 |
20.44% 684/1256 |
11.01% 588/1472 |
16.44% 528/1690 |
| 2019 | 37.47% 456/926 |
21.55% 1250/3054 |
0.18% 1285/3201 |
4.95% 512/939 |
7.57% 587/1014 |
| 2018 | -20.17% 166/668 |
- - |
- - |
- - |
-10.64% 2089/2977 |
| 2017 | 26.64% 95/531 |
- - |
- - |
- - |
- - |
| 2016 | -20.41% 303/455 |
- - |
- - |
- - |
- - |
| 2015 | 26.98% 319/433 |
- - |
- - |
- - |
- - |
| 2014 | 36.32% 83/432 |
- - |
- - |
- - |
- - |
| 2013 | 24.86% 94/398 |
- - |
- - |
- - |
- - |
| 2012 | 10.79% 80/459 |
- - |
- - |
- - |
- - |
| 2011 | -14.63% 26/392 |
- - |
- - |
- - |
- - |
| 2010 | -4.15% 271/335 |
- - |
- - |
- - |
- - |
| 2009 | 44.18% 231/270 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 56.52% |
| 招商创新增长混合A | 1.0759 | 55.91% |
| 招商创新增长混合C | 1.0235 | 55.61% |
| 招商品质成长混合A | 1.0435 | 55.01% |
| 华泰柏瑞医疗健康A | 2.6422 | 50.99% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 48.05% |
| 大摩优悦安和混合C | 0.8828 | 47.91% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 中信建投医药健康C | 0.7579 | 39.35% |
| 长信双利优选混合A VS. 长安宏观策略混合A(740001) |